Tong Victor Edward Jr 4

What Happened

• Victor Edward Tong Jr., a director of CG Oncology, was granted a derivative award covering 9,354 shares on 2026-06-04. The transaction is reported as an Award/Grant (code A) at $0.00 per share (no cash paid at grant). This was a grant of stock options (derivative securities), not a purchase or sale.

Key Details

• Transaction date: 2026-06-04; Filing date: 2026-06-05 (timely).
• Reported price: $0.00 per share (grant reported with no cash exchanged at time of grant).
• Number of shares/options granted: 9,354 (derivative securities).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Vesting: Footnote states 1/12th of the total option vests monthly beginning June 4, 2026; if the issuer’s next annual meeting occurs before the first anniversary, any remaining unvested portion will vest at that meeting, subject to continuous service.
• Transaction code: A = Award/Grant of derivative securities.

Context

• This was a time-based equity grant subject to vesting — the options were not exercised or sold. Such grants compensate and retain insiders and do not by themselves indicate immediate buying or selling pressure. For retail investors, vested or exercised purchases/sales convey clearer near-term insider conviction than unvested option grants.